Summary: Biomedical advances, new HIV testing technologies, and policy shifts in the last 15 years have created substantial new challenges and opportunities for service providers, policy makers, and researchers regarding broad scale identification of HIVseropositive persons. Effective HIV testing will be achieved when we: (1) increase the number of high-risk persons tested; (2) decrease the time from HIV infection to detection; (3) increase testing acceptability; (4) increase the proportion of individuals tested who receive their results; and (5) increase the proportion of individuals tested seropositive who are linked to care. Strategies to enhance effectiveness include implementing new testing technologies and delivery modalities; expanding access to clientcontrolled testing; targeting providers' knowledge, attitudes, and behaviors regarding HIV testing; mainstreaming HIV testing as routine clinical care; targeting persons who engage in high-risk behaviors and those in high-risk groups; and implementing a national behavioral surveillance system. Addressing these challenges will improve HIV detection in the United States, which is vital to both HIV prevention and treatment.
Since the introduction of HIV testing in 1985, 44% of adults in the United States have been tested (1) . The availability of testing has allowed us to establish a safe blood supply (2, 3) , to deliver preventive messages at the time of testing (1, 4) , and to link seropositive persons to care. Nonetheless, substantial gaps remain in the implementation and utilization of HIV testing.
The context of HIV testing has shifted dramatically as technological and biomedical advances and policy changes have occurred over the last 15 years. This article provides an overview of past successes in implementing HIV testing, challenges that remain to be addressed, and suggestions for meeting these challenges to increase the effectiveness of HIV detection. "Effective" HIV detection is defined in this article by five criteria: the percentage of individuals accepting testing when offered; the time from infection to detection; the proportion of persons tested who are at high risk for HIV (in contrast to the worried well); the proportion who return for test results; and the proportion of those tested seropositive who are linked to care.
SHIFTING CONTEXT OF HIV TESTING
The implementation of HIV testing has resulted in major public health advances in at least five areas. First, HIV testing is broadly available. When initiated in 1985, HIV testing was available only in anonymous public test sites (5) . Today, HIV testing is available in a variety of settings: private and public primary health care services, specialized clinics, HIV-identified service centers, clinics serving those with sexually transmitted diseases (STDs), anonymous test sites, street outreach services, and local pharmacies. Second, the blood supply is safe. In the early years of the epidemic, more than 16,000 hemophiliacs in the United States and over 12,000 blood transfusion recipients were infected from the blood supply (6) . The implementation of antibody testing in 1985 enabled screening of all donated blood for HIV (type 1; and type 2 in 1992), which resulted in a substantial de-crease of transmission through blood transfusions (2, 7, 8) . Third, a protocol for publicly funded HIV counseling and testing in the United States has been broadly implemented (9, 10) . Fourth, HIV counseling and testing appear to be effective intervention strategies for seropositive persons (11) (12) (13) (14) (15) (16) (17) (18) . Many persons who are aware of being HIV-seropositive reduce their risk acts substantially compared with those who test HIV-seronegative (18) ; fewer than 50% (typically only one third) of seropositive persons continue to engage in risk acts (16, (19) (20) (21) . The most consistent evidence of risk reduction subsequent to HIV counseling and testing has been documented among serodiscordant couples (18) ; rates of transmission have been reduced among heterosexual couples in San Francisco (22) and Rwanda (23) , and in gay male couples in New York City (24) . Fifth, HIV testing is a key component of many successful multisession HIV prevention programs that reduce rates of HIV transmission (e.g., National Institute of Mental Health National Multisite HIV Prevention Trial Group, [25, 26] ).
In addition to these successes, recent advances in HIV treatment have highlighted the importance of knowing one's HIV serostatus (1, (27) (28) (29) . First, those identified as seropositive for HIV can potentially prolong the duration and quality of their lives by early intervention with highly active antiretroviral therapies (HAART) (30) (31) (32) . Second, pregnant seropositive women can take medications, have a cesarean delivery, and refrain from breastfeeding, reducing the risk of transmitting the virus to their babies from 25% to about 2% (33) . Third, intervention with HAART during the period of primary infection may significantly alter disease course and the spread of infection (34) (35) (36) (37) . Finally, given that viral load appears to be related to transmission (38) (39) (40) (41) , initiating therapy is likely to reduce transmission of the virus across various stages of illness because viral loads will be lower.
Finally, a series of policy shifts have occurred. Instead of reporting AIDS cases, most states have started reporting the names of persons testing seropositive for HIV. The evidence is mixed on the impact of this practice. Knowing the identity of seropositive persons may improve HIV surveillance and facilitate referrals to care, with little if any deleterious impact on HIV testing rates (42) . Other research suggests HIV reporting by name may prevent individuals from being tested (43, 44) and from returning for results (45) . Recent evidence suggests both the positive and negative effects of name-based surveillance may have been exaggerated (46) however, and HIV surveillance through a system of unique identifiers has been shown to be effective (47) . Confidential (in contrast to anonymous) testing offers the opportunity for partner notification, which may be a feasible (48, 49) and cost-effective measure to facilitate testing of high-risk individuals (50) . Community concerns must be addressed, however, so that partner notification is not misinterpreted as coercive or as a threat to confidentiality (51) .
In short, major biomedical and policy changes have irrevocably altered the context of HIV testing, creating new challenges for HIV service providers, policy makers, and researchers. Five goals are outlined below for effective HIV detection.
1. Increase the number of high-risk persons tested. It is estimated that one third of persons living with HIV (PLH) (i.e., 250,000 to 300,000 persons) are unaware of their serostatus (52) (53) (54) (55) . Thus, the benefits of early intervention (27, 29, 30 ) remain inaccessible to a significant proportion of PLH. Although persons at higher risk for HIV infection are more likely to be tested than those at low risk (56) , many of our HIV testing resources predominantly serve the worried well. For example, in Los Angeles only 10% of all clients tested are at high risk for HIV based on selfreported risk factors, and the proportion of low-risk clients being tested has increased over time (57) . 2. Decrease the time from infection to detection. Although recent treatment advances suggest the benefits of early intervention (27, 29, 30) , most individuals do not discover their serostatus until late in the disease spectrum. Wortley et al. (58) found that more than half (51%) of persons living with HIV discover they are infected within one year of their diagnosis with AIDS (about 10 years after infection); this figure is even higher among women (60%). More than a third (36%) of persons find out they are infected with HIV at the time they are diagnosed with AIDS (58) . Even among individuals who suspect they may have been exposed to HIV, testing is often delayed, sometimes for longer than a year (59, 60 (74) . Data from adolescent medicine clinics (75) suggests that only about 11% of identified youth living with HIV are linked to care (76) . Although linking seropositive persons to care is an important goal in itself, increasing the proportion of infected individuals who are referred to and followup in care will also help to decrease rates of HIV transmission. Viral load is often decreased among persons who are linked to care and adhere to their treatment regimens (36, (77) (78) (79) ; lower viral load is associated with decreased rates of HIV transmission (38) (39) (40) (41) .
STRATEGIES FOR INCREASING EARLY AND EFFECTIVE HIV DETECTION
A variety of strategies, some enabled by recent advances in HIV testing technologies, may help to achieve the goals outlined above and thereby facilitate effective HIV detection.
Implement New Testing Technologies and Delivery Modalities
Rapid testing can provide test results in 10 minutes (80) . Because the testing procedure and getting one's results occur in the same visit, the most immediate effect is to increase the proportion of individuals who receive their test results. The Centers for Disease Control (1) has estimated that if a 10-minute rapid test were implemented in public health settings, 700,000 more people would know their HIV serostatus, including 29% more seropositive and 50% more seronegative persons. Rapid testing also may increase testing acceptability by eliminating the current 2-to 4-week wait to receive results (21, 81) . Studies in a variety of testing venues, including prenatal and family planning clinics, methadone clinics, and STD clinics have shown that delays in scheduling pre-or posttest counseling and client reported difficulties in returning for results deter use of testing (66) . Rapid testing in a Texas anonymous test site resulted in a 4% increase in seronegative persons and a 16% increase in seropositive persons being tested; a 210% increase in seronegative persons and a 23% increase in seropositive persons being tested in an STD clinic (81) . International studies also support the efficacy and reliability of rapid testing (82) (83) (84) . Based on a growing body of evidence, a recent Institute of Medicine report (85) calls for accelerated efforts to develop and approve additional rapid testing technologies in the Unites States.
In order to fully realize the benefits of new testing technologies, counseling and testing protocols as well as the delivery modalities for HIV testing must be revisited. International (86) as well as national (10) standards call for a one hour pre-and posttest counseling interview and a blood test to identify HIV serostatus. At an earlier time in the epidemic, requiring two clinic visits and conducting individual pre-and posttest counseling may have been sound public policy; now, however, these procedures may create barriers to identifying seropositive individuals. Additionally, current pre-and posttest guidelines often are not followed (87) (88) (89) . Individuals who obtained testing in private settings, for example, reported receiving pre-and posttest counseling less frequently than those who underwent testing in public settings (pre: public 58%; private 39%; post: public 43%; private 25%) (90) . Furthermore, many individuals do not want faceto-face counseling (91) . In a recent study, 95% of highrisk individuals opted for telephone rather than face-toface counseling when given a choice (92) . Evidence suggests that HIV test counselors may be more concerned about the dangers of telephone posttest counseling then their clients, and may underestimate the ability of clients to implement home testing (92) .
Despite the high proportion of individuals who do not accept HIV testing and who fail to return for results, only a few variations to traditional HIV counseling and testing procedures have been examined. The use of telephone rather than face-to-face counseling has increased the rate of testing (91, 93) . Similarly, the use of videos in pretest counseling increased rates of HIV testing (72, 94) . Among adolescents, peer-based counseling has been used to motivate youth to test for HIV, but did not increase rates of testing (95) . Given the substantial innovation occurring on the Internet and in broadcast media, far more innovation is possible in the delivery of pre-and posttest counseling. The existing HIV counseling and testing protocol, appropriate to an earlier time in the epidemic, may be incommensurate with current technologies and treatments. In effect, some individuals are deterred from being tested and from receiving their results.
In addition to rapid testing, broad implementation of inexpensive, saliva-based tests may increase testing acceptability. In particular, oral tests may appeal to those who fear venipuncture and persons who tend to be distrustful of public health programs (96) . The convenience of oral testing also may facilitate bringing testing to high-risk populations (e.g., in gay bars [97] ). Oral testing is also preferred to dried blood spot tests among persons using home test kits (92) .
Increase Access to Client-Controlled Testing
In addition to advances offered by rapid on-site testing, home testing also may increase testing acceptability and the proportion of those who receive their results. Ethnic minorities, in particular (among those with the lowest testing acceptance and return rates) may prefer home testing versus public testing given heightened concerns regarding stigma and distrust of public health authorities (96, 98) . After a de facto ban on home HIV testing by the FDA for almost a decade (99), and contentious debates (100), home HIV testing was made available in 1995 (101) . Because the home test is not entered into any medical record, its users have been able to circumvent many state laws requiring face-to-face counseling (91) . Nonetheless, home test kits are available only to those with the means to pay out of pocket (US$40-US$50), and remain inaccessible to these who are least able to pay, least likely to be tested, and often at high risk for HIV.
Current home test kits require that one prepare a blood sample at home, mail in the sample, and call in to a third party using an anonymous identifier 2 to 3 days later to receive results. Rapid testing presents the possibility of using a simple screening test that can be conducted entirely at home without third party involvement. Rapid in-home tests would be inherently anonymous, because only the person doing the testing knows his or her results. If the screening test were positive, the individual would be referred to a medical provider by an accompanying brochure for confirmatory testing and counseling. Rapid in-home testing might further increase the numbers of individuals who know their HIV status during the early stages of infection (102) . Although public health officials would not be informed of the person's disease status, it is likely, based on other studies, that individuals would both decrease risk acts and seek care (92, 103) .
Rapid self-testing at home presents a challenge to existing Food and Drug Administration standards, which emphasize that results be given only be a trained professional, and include pre-and posttest counseling, informed consent, and use of confirmatory tests before informing persons of their HIV test results. These standards may have been appropriate at a time when therapeutic options for HIV treatment were limited, but they must be reevaluated in light of the substantial benefits that now accrue from individuals' becoming aware of their HIV serostatus (e.g., due to HAART). Accordingly, several investigators suggest the benefits of rapid home testing may outweigh the risks and call for its approval and cautious dissemination (91, 102) . In a recent Los Angeles-based study, most individuals agreed that rapid inhome testing should be made available, and 44% indicated they would prefer such a test to clinic testing (104).
Target Providers' Knowledge, Attitudes, and Behaviors
Medical providers (e.g., physicians, nurse practitioners) represent a vital resource for increasing the effectiveness of HIV detection. Providers have been demonstrated to influence consumers' HIV testing acceptance: repeated encouragement to test by clinicians increases HIV testing (105) . For example, 73% of persons who initially refused HIV counseling and testing at an STD clinic accepted them when offered testing at a later visit (106) . Studies in perinatal care settings indicate that a healthcare provider's pro-testing attitude is linked to higher levels of testing acceptance (107) (108) (109) . Medical providers also have a major role to play in recognizing the physical signs of early infection, (e.g., flu-like symptoms) and referring patients for HIV testing and subsequent care (110) . Additionally, public health officials
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and providers could teach those at high risk to recognize possible signs of early infection.
Despite the pivotal role of medical providers, AIDS and HIV testing is not always adequately addressed by providers with their patients (111-113) ; often patients, rather than their providers, initiate conversations regarding HIV testing, even when pregnant (114) or an adolescent at high risk for HIV (115) . Wide gaps and variability in health care providers' knowledge of HIV testing and transmission have been reported (116) . Seventeen percent of providers believe HIV tests are inaccurate; 14% that tests always indicate current serostatus; and 47% do not know that increased viral load during the period of early infection is related to higher rates of transmission (116) . In past research, most mental health workers (55%) indicated they did not want HIVpositive clients (110) . These data may help to explain divergent practices among providers in initiating discussion of and encouraging HIV testing among patients who may be at risk. Thus, increases in provider knowledge and experience may be a necessary component to increased test acceptance, as well as earlier HIV testing among persons at risk.
Larger organizational aspects of HIV testing may influence providers' behaviors as well as the testing behaviors of their patients. For example, limited research suggests patients' acceptance of HIV testing is related to the perception by managers that the program had an adequate number of counseling and testing providers (117) . Organizational factors such as the coordination, comprehensiveness, and continuity of HIV services have been linked to the quality of HIV care (118) and may influence the effectiveness of HIV testing, as well. To our knowledge, there are no studies of organizational processes (e.g., client and staff monitoring), structures (e.g., agency rules and protocols, clinic on-site vs. satellite clinic), or interorganizational relationships among providers of HIV testing, all of which may influence individuals' testing behaviors. Investigation of organizational factors in HIV testing is an important area for future research, particularly because HIV testing has moved from public to private settings.
The number of HIV tests in the public sector has stabilized at around 2.5 million tests per year (1) . Therefore, with 25 million tests annually (1, 80) , HIV testing in the public sector represents only about 10% of all HIV testing conducted (54). Most HIV testing takes place in hospitals and clinics (54%), with blood donation centers (32%), publicly funded sites (10%), and the military (4%) accounting for the remainder of HIV testing venues (54,119,120). Limited research suggests that public/ private status may influence key procedures related to testing (66) . Several studies have raised concerns about the adequacy of information and referrals from providers in private testing venues (87, 89, 121, 122) .
As increasing numbers of Americans have been tested and the sites have shifted to private settings, health care delivery in the U.S. has moved to managed care. Managed care organizations, providers in fee-for-service settings, and public sector venues may promote and implement HIV testing for their clients in very different ways. Clients' medical insurance is related to income and education, which in turn is associated with ethnic minority status and cultural differences across organizations' clienteles (123) . Differences in client populations and funding levels may be vital factors in explaining different organizational styles for delivering HIV care (124) . However, currently we know little about how these different organizational settings relate to provider behaviors or HIV testing effectiveness.
Mainstream HIV Testing as Routine Clinical Care
Mainstreaming of HIV testing refers to offering HIV testing as a routine procedure in primary health care with an informed right of refusal (i.e., voluntary opt-out), rather than relying on client requests for testing (i.e., voluntary opt-in) (76, 125) . In routine testing, the burden is shifted from those who would want to take an HIV test to those who want to refuse testing. Mainstreaming may increase testing acceptance by taking the burden off of those who wish to be tested, as well as by decreasing stigma and marginalization of HIV/AIDS (126, 127) . Instituting routine HIV testing among adolescents seeking STD related services resulted in the testing of thousands of youth (128) . Routine testing in STD clinics using an opt-out approach resulted in 67% (n ‫ס‬ 31,558) being tested vs. 47% (n ‫ס‬ 34,511) using a targeted opt-in approach (103) . Similarly, routine testing in tuberculosis clinics may be effective in identifying seropositives among a high-risk population (129, 130) . A 96% acceptance rate was reported for routine HIV testing in a Texas tuberculosis clinic, with 13% found seropositive (130) . In a Scotland study, prenatal HIV testing increased from 18% to 90% when the approach was switched from optin to opt-out (131) . The American College of Obstetricians and Gynecologists (132) , as well as an Institute of Medicine (6) report, now recommends that all pregnant women be tested for HIV during routine prenatal care.
Routine HIV testing is also supported by data that suggest selectively offering HIV testing on the basis of individuals' self-reported risk behavior misses as many as 35% of seropositive persons (133) ; self-reported risk behavior may fail to distinguish seropositive individuals from seronegative individuals (130) . The continued mainstreaming of HIV testing may be facilitated by the availability of new treatments and the increased longevity of persons living with HIV/AIDS, which may promote the perception of HIV/AIDS as a manageable chronic illness rather than a fatal disease.
Focus on Persons Who Engage in High-Risk
Behavior and High-Risk Groups
Given that testing sites predominantly serve the worried well, it is necessary to tailor interventions and outreach to persons and communities at high risk. Wide variations in testing rates have been reported among different high-risk populations: 60% among gay men; 46% among male injection drug users (IDUs); and 13% among female IDUs (134) , suggesting the need for targeted interventions.
Methods for increasing the numbers of high-risk individuals tested include community outreach efforts (97, 135, 136) ; increased testing accessibility (97, 103, 129, 130, 136) ; partner notification (137); postexposure prophylaxis for sexual transmission (138, 139) ; and tailored social marketing of HIV testing (28, 76, 128) . Several types of outreach have been demonstrated to increase testing rates. Church-based efforts for disseminating HIV testing information, for example, have demonstrated success among communities of color and may increase early detection (135) . Mobile outreach vans dispatched to areas with high seroprevalence rates and to high-risk individuals (e.g., IDUs, commercial sex workers, inner city ethnic minority neighborhoods, and public sex environments) may increase the number of seropositive persons tested. In one study, HIV prevalence was 26.5% at a mobile testing van vs. 5.4% in a comparable clinic; but return rates appear to be a problem (20% van vs. 79% clinic; (136) , necessitating improved follow-up strategies or rapid on-site testing. Similarly, outreach efforts that brought oral HIV testing to gay bars yielded a 54% acceptance rate, with 6% testing seropositive, and 22% tested for the first time (97) . Offering routine testing in tuberculosis (129, 130) and STD clinics (103) may be another effective strategy for increased testing among high-risk individuals.
In order to determine HIV seropositivity closer to the time of infection, repeated HIV testing might be promoted among high-risk individuals and populations (92, 140) . Although repeat testing may have a secondary effect of decreasing risk behavior (92, 105) , it also may have a paradoxical effect: repeat negative testing, particularly among youth who repeatedly engage in highrisk behaviors, may foster notions of invulnerability that enable risk behavior (141, 142) . Gay men with a history of three or more previous HIV tests reported higher levels of risk behavior (42%) than gay men with two or less past tests (25%) (143) , which may suggest that repeat testing is used in lieu of behavioral risk reduction among some individuals. Thus, although repeat testing among high-risk persons may help to decrease the time from infection to detection, it should not be promoted as an HIV prevention strategy in itself; repeat testing should incorporate behavioral interventions to reduce risk.
Overall, increased funding and research to implement culturally appropriate, tailored social marketing of HIV testing to individuals and populations at high risk for HIV, and least likely to be tested (e.g., inner city adolescents), may be vital to promoting early detection (28, 76) . In particular, messages must be tailored for high-risk and untested populations, so as not to increase testing predominantly among the worried well (28) . For example, a social marketing campaign in New York City aimed at increasing adolescent testing resulted in several hundred youth seeking testing (128) .
Implement a National Behavioral Surveillance System
Currently, in 38 states, all new cases of HIV are reported to the Centers for Disease Control; the remaining states report only AIDS cases or use unique identifier systems for monitoring the epidemic. Due to delays in testing, these data reflect the status of the epidemic 10 years before (58, 85) . To effectively design prevention and care programs, we need an ongoing system for monitoring the HIV risk behaviors of the nation, with a special emphasis on persons at high risk for HIV. National surveys are routinely conducted for drug abuse, health behaviors, labor, and employment; HIV risk behaviors need to be monitored in a similar manner. A behavioral surveillance system would allow allocation of resources for newly emerging pockets of infection and provide data for mounting national prevention programs (e.g., national social marketing campaigns, similar to those mounted for substance abuse).
SUMMARY
Early detection of HIV is increasingly a cornerstone of HIV prevention and treatment. Many opportunities exist for promoting and facilitating effective early detection, including implementation of new testing technologies (e.g., rapid home testing) and innovative delivery modalities (e.g., initial HIV screening without face-to-face pretest counseling). Such innovations do not come with-
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out risks, however, and should be approached responsibly and with caution. Yet, failing to act in light of recent advances in HIV testing technologies and HIV treatment may present greater risks to public health in the end than in deciding to move forward. In 1977, editorials in the American Journal of Public Health warned professionals of the hazards of home pregnancy tests (144) (145) (146) (147) ; today these tests are routine and widely accepted. In an era of home pregnancy testing, self-tests to screen for colorectal cancer, and self breast examinations, rapid self-testing for HIV may add to the array of client-controlled technologies through which consumers are increasingly enabled to become partners with their healthcare providers in detecting disease and promoting health.
Understandably, efforts to increase early detection of HIV are focused on the one third of persons living with HIV who are unaware of their seropositive status. Increased efforts also must converge on the one third of seropositive persons who are not linked to care. Disparities in HIV/AIDS care by race/ethnicity, gender, age, and insurance status (74, 148, 149) , and concomitant decreases in AIDS incidence and mortality that disproportionately benefit whites relative to black Americans and Latinos (150) may help to explain why ethnic minorities are more likely to refuse testing (151) , to report no past HIV testing (152) , and less likely to have their HIV infections detected early (153) . In the absence of appropriate and accessible medical treatment, individuals' incentives to be tested early, much less at all, may be diminished.
In conclusion, efforts at promoting and mainstreaming HIV testing, and making protocols and procedures more client centered, must be accompanied by a focus on linking individuals who test positive to care and using testing as an opportunity to facilitate and reinforce behavioral risk reduction. Accordingly, it is imperative to ensure that appropriate and accessible HIV prevention and care is universally available. Ultimately, the success of early detection is bounded by the efficacy of the linkages between HIV testing, HIV treatment, and prevention.
